Published in

Nature Research, Nature Cancer, 6(2), p. 598-610, 2021

DOI: 10.1038/s43018-021-00203-x

Links

Tools

Export citation

Search in Google Scholar

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

Journal article published in 2021 by Jia Zhou ORCID, Camille Gelot ORCID, Constantia Pantelidou ORCID, Adam Li, Hatice Yücel, Rachel E. Davis, Anniina Färkkilä ORCID, Bose Kochupurakkal, Aleem Syed ORCID, Geoffrey I. Shapiro, John A. Tainer, Brian S. J. Blagg, Raphael Ceccaldi ORCID, Alan D. D’Andrea ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO